Medifast (MED) to Release Earnings on Monday

Medifast (NYSE:MED - Get Free Report) is expected to be posting its Q1 2025 quarterly earnings results after the market closes on Monday, April 28th. Analysts expect the company to announce earnings of ($0.20) per share and revenue of $114.85 million for the quarter. Medifast has set its Q1 2025 guidance at -0.500-0.000 EPS.

Medifast (NYSE:MED - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The specialty retailer reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.26. Medifast had a net margin of 0.35% and a return on equity of 10.64%. The firm had revenue of $119.00 million for the quarter, compared to analyst estimates of $114.25 million. On average, analysts expect Medifast to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Medifast Stock Performance

NYSE MED traded up $0.15 during trading hours on Friday, hitting $12.32. 121,336 shares of the company traded hands, compared to its average volume of 320,563. The stock has a market capitalization of $134.76 million, a price-to-earnings ratio of 68.44 and a beta of 1.05. Medifast has a twelve month low of $11.57 and a twelve month high of $36.30. The business's 50-day moving average is $13.54 and its 200-day moving average is $16.17.

Analyst Ratings Changes

Separately, DA Davidson dropped their price target on shares of Medifast from $17.00 to $16.50 and set a "neutral" rating on the stock in a research report on Wednesday, February 19th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.